m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance.
第一作者:
Tengfei,Zhou
第一单位:
International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
作者:
主题词
动物(Animals);抗体, 嗜异性(Antibodies, Heterophile);癌, 肝细胞(Carcinoma, Hepatocellular);细胞去分化(Cell Dedifferentiation);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);肝细胞核因子3γ(Hepatocyte Nuclear Factor 3-gamma);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);小鼠(Mice);肿瘤蛋白质类(Neoplasm Proteins);肿瘤移植(Neoplasm Transplantation);RNA加工, 转录后(RNA Processing, Post-Transcriptional);RNA, 信使(RNA, Messenger);RNA, 肿瘤(RNA, Neoplasm)
DOI
10.1038/s41392-020-00299-0
PMID
33361765
发布时间
2021-10-13
- 浏览0

Signal transduction and targeted therapy
2020年5卷1期
296页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文